EUVIMEDEUVIMED entdecken
Fallbericht

Tigecycline Induced Sweet Syndrome in a Patient on Maintenance Hemodialysis

Periklis Dousdampanis iD, Eleni Koutroulia, Pinelopi Nterma, Christos Siavelis, Elefteria Sarri, Georgia Kiriakou, Panagiotis Aroukatos, Zoi Tegou

Hemodialysis International · 2025

DOI: 10.1111/hdi.13248 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Hemodialysis International, 2025. Verfasst von Periklis Dousdampanis und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Geniko Nosokomeio Patron Agios Andreas, Patra, Greece. Hauptthemen laut MEDLINE: Sweet Syndrome, Renal Dialysis, Minocycline, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sweet syndrome or acute febrile neutrophilic dermatosis is a very uncommon condition, especially in patients on chronic hemodialysis. Sweet syndrome is characterized by painful erythematous plaques, papules, and nodules of abrupt onset, associated with fever and malaise. We describe a 44‐year‐old woman on chronic hemodialysis due to diabetic nephropathy who developed Sweet syndrome after intravenous administration of tigecycline due to an enterococcus infection. There is a paucity of data regarding Sweet syndrome in hemodialysis patients; nevertheless, this syndrome merits more attention in nephrological clinical practice. We suggest that Sweet syndrome should be considered if the abrupt appearance of erythematous plaques and nodules with fever is presented in a hemodialysis patient. Nephrologists should be aware of this uncommon condition in order to timely recognize this syndrome. Interestingly, tigecycline is another drug implicated in the development of drug‐induced Sweet syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sweet SyndromeRenal DialysisMinocyclineAnti-Bacterial AgentsHumansFemaleTigecyclineAdult

Stichwörter der Autor:innen

Sweet syndromeacute febrile neutrophilic dermatosishemodialysistigecycline

Substanzen

TigecyclineMinocyclineAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Nephrology, Geniko Nosokomeio Patron Agios Andreas, Patra, Greece.
  • Department of Dermatology, Geniko Nosokomeio Patron Agios Andreas, Patra, Greece.
  • Department of Pathology, Geniko Nosokomeio Patron Agios Andreas, Patra, Greece.

ORCID-Profile: Periklis Dousdampanis

Zitieren

APA

Dousdampanis, P., Koutroulia, E., Nterma, P., Siavelis, C., Sarri, E., Kiriakou, G., Aroukatos, P., & Tegou, Z. (2025). Tigecycline Induced Sweet Syndrome in a Patient on Maintenance Hemodialysis. Hemodialysis International. https://doi.org/10.1111/hdi.13248

Vancouver

Dousdampanis P, Koutroulia E, Nterma P, Siavelis C, Sarri E, Kiriakou G, et al. Tigecycline Induced Sweet Syndrome in a Patient on Maintenance Hemodialysis. Hemodialysis International. 2025. doi:10.1111/hdi.13248

BibTeX
@article{Dousdampanis2025,
  author = {Dousdampanis, Periklis and Koutroulia, Eleni and Nterma, Pinelopi and Siavelis, Christos and Sarri, Elefteria and Kiriakou, Georgia and Aroukatos, Panagiotis and Tegou, Zoi},
  title = {Tigecycline Induced Sweet Syndrome in a Patient on Maintenance Hemodialysis},
  journal = {Hemodialysis International},
  year = {2025},
  doi = {10.1111/hdi.13248}
}
Kostenlos starten →